Overview: issues concerning the pharmacology of multiple drug regimens

Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production.

Human & experimental toxicology·2004

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.

Antimicrobial agents and chemotherapy·2001

Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.

Antimicrobial agents and chemotherapy·1999

The effect of increasing gastric pH upon the bioavailability of orally-administered foscarnet.

Antiviral research·1998

Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults.

Antimicrobial agents and chemotherapy·1998

Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection.

AIDS (London, England)·1998

Application of Emerging Technologies in the Antiviral Field.

Antiviral research·2026

High-yield production of immunogenic PV3 virus-like particle in yeast.

Antiviral research·2026

Field-isolate recombinant tick-borne encephalitis viruses define reporter-stability guidelines for antiviral testing in flaviviruses.

Antiviral research·2026

Class I capsid assembly modulators induce potent anti-HBV activity through direct viral suppression, innate immune activation and caspase-3-independent clearance of infected hepatocytes.

Antiviral research·2026

Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing.

Antiviral research·2026

Dual-targeting engineered binding proteins block SARS-CoV-2 infection and complement activation.

Antiviral research·2026

Comparative effectiveness of ceftolozane/tazobactam relative to ceftazidime/avibactam for the treatment of adult, hospitalized patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa in U.S. Veterans Health Administration facilities.

Antimicrobial agents and chemotherapy·2026

In vitro pharmacodynamics of the antimalarial drug cabamiquine.

Antimicrobial agents and chemotherapy·2026

The Ethics of Growth-Promoting Pharmaceuticals for Achondroplasia.

The American journal of bioethics : AJOB·2026

Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fournier Gangrene: A Disproportionality Analysis Using the Japanese Adverse Drug Event Report Database.

American journal of therapeutics·2026

Pharmacophore-Based Virtual Screening for Identification of Adenosine Deaminase Inhibitors.

Iranian journal of pharmaceutical research : IJPR·2026

Effectiveness of fluoxetine and mindfulness therapy in improving depression in people with Type 2 Diabetes Mellitus in Primary Care Settings (DIAMAND)-A single-blind, parallel-group, randomized controlled trial from Bengaluru.

Indian journal of psychiatry·2026

Related Experiment Videos

Overview: issues concerning the pharmacology of multiple drug regimens

Related Concept Videos

Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production.

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.

Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.

The effect of increasing gastric pH upon the bioavailability of orally-administered foscarnet.

Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults.

Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection.

Application of Emerging Technologies in the Antiviral Field.

High-yield production of immunogenic PV3 virus-like particle in yeast.

Field-isolate recombinant tick-borne encephalitis viruses define reporter-stability guidelines for antiviral testing in flaviviruses.

Class I capsid assembly modulators induce potent anti-HBV activity through direct viral suppression, innate immune activation and caspase-3-independent clearance of infected hepatocytes.

Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing.

Dual-targeting engineered binding proteins block SARS-CoV-2 infection and complement activation.

Comparative effectiveness of ceftolozane/tazobactam relative to ceftazidime/avibactam for the treatment of adult, hospitalized patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa in U.S. Veterans Health Administration facilities.

In vitro pharmacodynamics of the antimalarial drug cabamiquine.

The Ethics of Growth-Promoting Pharmaceuticals for Achondroplasia.

Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fournier Gangrene: A Disproportionality Analysis Using the Japanese Adverse Drug Event Report Database.

Pharmacophore-Based Virtual Screening for Identification of Adenosine Deaminase Inhibitors.

Effectiveness of fluoxetine and mindfulness therapy in improving depression in people with Type 2 Diabetes Mellitus in Primary Care Settings (DIAMAND)-A single-blind, parallel-group, randomized controlled trial from Bengaluru.

Related Experiment Videos

Overview: issues concerning the pharmacology of multiple drug regimens

Related Concept Videos

Related Articles